ArticleCommunications biology2026
Evolution, structure and function of the putative biosynthetic gene cluster of the fungal secondary metabolite myriocin, a potent inhibitory sphingolipid.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Myriocin is a fungal secondary metabolite exploited worldwide as a powerful inhibitor of sphingolipid biosynthesis through its structural similarity to sphingosine. We identify the putative myriocin biosynthesis gene cluster (BGC) through de novo sequencing of two producing fungi, Isaria sinclairii and Mycelia sterilia, yielding genomes of 25.2 Mb and 34.2 Mb encoding 27 and 20 secondary metabolite BGCs, respectively. BGCs #5 in I. sinclairii and #18 in M. sterilia both shared and expressed the polyketide synthase (PKS) and alpha oxo-amine synthase (AOS) predicted for myriocin biosynthesis, with 74% and 79% sequence similarity, respectively. Analysis of a 2,236-fungal-genome database suggests the pathway originated in the Sordariomycete ancestor, presenting in two major clades distinguished by PKS gene orientation. The placement of thermophilic M. sterilia suggests myriocin BGC acquisition through horizontal gene transfer, but its origin in I. sinclairii is ambiguous. Heterologously-expressed IsMyrA bound aminomalonate, and a protein-protein docking interface was identified between the acyl carrier protein and IsMyrA. A model of PKS domain function, the roles of the PKS and AOS genes and the synteny of the putative myriocin biosynthetic gene cluster across 34 carrier species of ascomycetes is presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.